Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 51655-818

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 51655-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-818-26 (51655 818 26 Rev A 01 23)

51655-818-26 (51655 818 26   Rev A 01 23)
This is a description of Cyclobenzaprine Hydrochloride Tablets, USP with 5mg strength, containing 90 tablets per package. The tablets should be stored at 20° - 25°C (68° - 77°F) and kept in their original container, tightly closed, and out of reach of children. The medication is prescribed by a doctor and a package insert with dosage instructions is provided. The manufacturer is Advagen Pharma Ltd and the repackager is Northwind Pharmaceuticals located in Indianapolis, IN. The Global Trade Identification Number (GTIN) for the product is 00351655818268, with a serial number of 000000000000000. The expiration date is 00/00/0000 and LOT number is 0000000000.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.